137 related articles for article (PubMed ID: 9551682)
1. Histopathological evaluation of liver fibrosis: quantitative image analysis vs semi-quantitative scores. Comparison with serum markers.
Pilette C; Rousselet MC; Bedossa P; Chappard D; Oberti F; Rifflet H; Maïga MY; Gallois Y; Calès P
J Hepatol; 1998 Mar; 28(3):439-46. PubMed ID: 9551682
[TBL] [Abstract][Full Text] [Related]
2. Respective roles of porto-septal fibrosis and centrilobular fibrosis in alcoholic liver disease.
Michalak S; Rousselet MC; Bedossa P; Pilette C; Chappard D; Oberti F; Gallois Y; Calès P
J Pathol; 2003 Sep; 201(1):55-62. PubMed ID: 12950017
[TBL] [Abstract][Full Text] [Related]
3. Non invasive prediction of severe fibrosis in patients with alcoholic liver disease.
Tran A; Hastier P; Barjoan EM; Demuth N; Pradier C; Saint-Paul MC; Guzman-Granier E; Chevallier P; Tran C; Longo F; Schneider S; Piche T; Hebuterne X; Benzaken S; Rampal P
Gastroenterol Clin Biol; 2000; 24(6-7):626-30. PubMed ID: 10962384
[TBL] [Abstract][Full Text] [Related]
4. Noninvasive diagnosis of hepatic fibrosis or cirrhosis.
Oberti F; Valsesia E; Pilette C; Rousselet MC; Bedossa P; Aubé C; Gallois Y; Rifflet H; Maïga MY; Penneau-Fontbonne D; Calès P
Gastroenterology; 1997 Nov; 113(5):1609-16. PubMed ID: 9352863
[TBL] [Abstract][Full Text] [Related]
5. [Comparison of six potential serum markers of hepatic fibrosis in alcoholic disease of the liver].
Grimbert S; Trinchet JC; Hartmann DJ; Munz C; Garnier M; Mal F; Callard P; Beaugrand M
Gastroenterol Clin Biol; 1993; 17(8-9):570-7. PubMed ID: 8253314
[TBL] [Abstract][Full Text] [Related]
6. A novel panel of blood markers to assess the degree of liver fibrosis.
Calès P; Oberti F; Michalak S; Hubert-Fouchard I; Rousselet MC; Konaté A; Gallois Y; Ternisien C; Chevailler A; Lunel F
Hepatology; 2005 Dec; 42(6):1373-81. PubMed ID: 16317693
[TBL] [Abstract][Full Text] [Related]
7. [Procollagen III and laminin in chronic viral hepatopathies].
Montalto G; Soresi M; Aragona F; Tripi S; Carroccio A; Anastasi G; Magliarisi C; Barresi E; Notarbartolo A
Presse Med; 1996 Jan; 25(2):59-62. PubMed ID: 8745719
[TBL] [Abstract][Full Text] [Related]
8. Quantitative assessment of fibrosis in liver biopsies from patients with chronic hepatitis B.
Hui AY; Liew CT; Go MY; Chim AM; Chan HL; Leung NW; Sung JJ
Liver Int; 2004 Dec; 24(6):611-8. PubMed ID: 15566512
[TBL] [Abstract][Full Text] [Related]
9. Image analysis of liver collagen using sirius red is more accurate and correlates better with serum fibrosis markers than trichrome.
Huang Y; de Boer WB; Adams LA; MacQuillan G; Rossi E; Rigby P; Raftopoulos SC; Bulsara M; Jeffrey GP
Liver Int; 2013 Sep; 33(8):1249-56. PubMed ID: 23617278
[TBL] [Abstract][Full Text] [Related]
10. Prothrombin index is an indirect marker of severe liver fibrosis.
Croquet V; Vuillemin E; Ternisien C; Pilette C; Oberti F; Gallois Y; Trossaert M; Rousselet MC; Chappard D; Calès P
Eur J Gastroenterol Hepatol; 2002 Oct; 14(10):1133-41. PubMed ID: 12362105
[TBL] [Abstract][Full Text] [Related]
11. Non-invasive fibrosis seromarkers as a predictor of liver fibrosis in chronic hepatitis C and/or non-alcoholic steatohepatitis.
Ahmed L; Salama H; Ahmed R; Hamdy S; Al-Akel W; Shafi SA; Mahgoub A; Hareedy A; Fathy W
Arab J Gastroenterol; 2009 Mar; 10(1):14-20. PubMed ID: 24842131
[TBL] [Abstract][Full Text] [Related]
12. Comparison of serum procollagen III peptide concentrations and PGA index for assessment of hepatic fibrosis.
Teare JP; Sherman D; Greenfield SM; Simpson J; Bray G; Catterall AP; Murray-Lyon IM; Peters TJ; Williams R; Thompson RP
Lancet; 1993 Oct; 342(8876):895-8. PubMed ID: 8105167
[TBL] [Abstract][Full Text] [Related]
13. Serum type I collagen and N-terminal peptide of type III procollagen in chronic hepatitis. Relationship to liver histology and conventional liver tests.
Trinchet JC; Hartmann DJ; Pateron D; Laarif M; Callard P; Ville G; Beaugrand M
J Hepatol; 1991 Mar; 12(2):139-44. PubMed ID: 1711064
[TBL] [Abstract][Full Text] [Related]
14. The Enhanced Liver Fibrosis (ELF) score: normal values, influence factors and proposed cut-off values.
Lichtinghagen R; Pietsch D; Bantel H; Manns MP; Brand K; Bahr MJ
J Hepatol; 2013 Aug; 59(2):236-42. PubMed ID: 23523583
[TBL] [Abstract][Full Text] [Related]
15. Serum markers of hepatocyte death and apoptosis are non invasive biomarkers of severe fibrosis in patients with alcoholic liver disease.
Lavallard VJ; Bonnafous S; Patouraux S; Saint-Paul MC; Rousseau D; Anty R; Le Marchand-Brustel Y; Tran A; Gual P
PLoS One; 2011 Mar; 6(3):e17599. PubMed ID: 21445263
[TBL] [Abstract][Full Text] [Related]
16. The levels of serum fibrosis marks and morphometric quantitative measurement of hepatic fibrosis.
Xie SB; Yao JL; Zheng SS; Yao CL; Zheng RQ
Hepatobiliary Pancreat Dis Int; 2002 May; 1(2):202-6. PubMed ID: 14607739
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of hepatic fibrosis by serum proline and amino-terminal type III procollagen peptide levels in alcoholic patients.
Tanaka Y; Minato Y; Hasumura Y; Takeuchi J
Dig Dis Sci; 1986 Jul; 31(7):712-7. PubMed ID: 3720468
[TBL] [Abstract][Full Text] [Related]
18. Relationship of serum fibrosis markers with liver fibrosis stage and collagen content in patients with advanced chronic hepatitis C.
Fontana RJ; Goodman ZD; Dienstag JL; Bonkovsky HL; Naishadham D; Sterling RK; Su GL; Ghosh M; Wright EC;
Hepatology; 2008 Mar; 47(3):789-98. PubMed ID: 18175357
[TBL] [Abstract][Full Text] [Related]
19. Quantitative versus morphological assessment of liver fibrosis: semi-quantitative scores are more robust than digital image fibrosis area estimation.
Wright M; Thursz M; Pullen R; Thomas H; Goldin R
Liver Int; 2003 Feb; 23(1):28-34. PubMed ID: 12640724
[TBL] [Abstract][Full Text] [Related]
20. [Correlation between liver fibrosis stage and serum liver fibrosis markers in patients with chronic hepatitis B].
Ding H; Chen Y; Feng X; Liu D; Wu A; Zhang L
Zhonghua Gan Zang Bing Za Zhi; 2001 Apr; 9(2):78-80. PubMed ID: 11350682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
